AngioDynamics, Inc.
ANGO institutional ownership changes in Q2 2026: 55 institutions opened or added positions, 42 trimmed or exited. ANGO (AngioDynamics, Inc.) is held by 99 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($49.5M), Point72 Asset Management, L.P. ($39.8M), Royce & Associates LP ($25.6M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 4, 2026 · Activists May 15, 2026 · Congress Oct 24, 2025
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 3.8M(+3.2%) | $49.5M | 0.0% | +39.12% | 30 | |
Decreased | 3.1M(-3.8%) | $39.8M | 0.0% | +12.66% | 0 | |
Increased | 2M(+28.8%) | $25.6M | 0.2% | +23.32% | 43 | |
Decreased | 1.7M(-1.9%) | $22M | 0.0% | +3.17% | 0 | |
Decreased | 1.2M(-1.4%) | $15.6M | 0.0% | +12.96% | 0 | |
Increased | 1M(+3.6%) | $13.3M | 0.0% | -28.81% | 29 | |
Increased | 969,497(+2.2%) | $12.6M | 0.0% | -24.93% | 29 | |
Decreased | 958,167(-28.2%) | $12.5M | 0.0% | -17.87% | 0 | |
Increased | 783,125(+21.5%) | $10.2M | 0.0% | +12.93% | 33 | |
Decreased | 733,883(-8.6%) | $9.5M | 0.0% | +12.43% | 0 | |
Decreased | 692,534(-8.7%) | $9M | 0.0% | +16.56% | 0 | |
Increased | 589,157(+134.2%) | $7.7M | 0.0% | -5.38% | 44 | |
Increased | 440,844(+1.0%) | $5.7M | 0.0% | +3.02% | 27 | |
Decreased | 420,378(-13.4%) | $5.5M | 0.0% | +17.97% | 0 | |
Increased | 382,917(+21.9%) | $5M | 0.0% | -4.86% | 32 | |
Increased | 374,029(+11.8%) | $4.9M | 0.0% | -31.67% | 30 | |
Decreased | 345,143(-31.5%) | $4.5M | 0.0% | +6.50% | 0 | |
Increased | 329,727(+6.1%) | $4.3M | 0.0% | -45.60% | 28 | |
Increased | 306,260(+32.9%) | $4M | 0.0% | -3.51% | 34 | |
Increased | 276,915(+1.2%) | $3.6M | 0.0% | +2.99% | 27 |
Showing 1-20 of 105
ANGOAngioDynamics, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about ANGO
Who owns ANGO?
99 institutional investors held ANGO on June 30, 2026, led by BlackRock, Inc. ($49.5M), Point72 Asset Management, L.P. ($39.8M) and Royce & Associates LP ($25.6M).
How many hedge funds hold ANGO?
99 institutional investors reported ANGO in their 13F filings for the quarter ended June 30, 2026, $316.1M in all. 5 of them are rated Elite.
Are institutions buying or selling ANGO?
Buying, on balance. In Q2 2026, 55 institutions opened or added to positions in ANGO and 42 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer